STAGE IIIA NON-SMALL CELL LUNG CANCER
Clinical trials for STAGE IIIA NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIA NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for STAGE IIIA NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope: targeted pill before surgery for lung cancer
Disease control OngoingThis study tests whether giving the targeted drug osimertinib before surgery can shrink tumors in people with early-stage EGFR-mutant non-small cell lung cancer. About 27 adults with stage I to IIIA disease will receive the drug before their operation. The main goal is to see how…
Matched conditions: STAGE IIIA NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC
-
New drug combo shows promise in Hard-to-Treat cancers
Disease control OngoingThis early-phase study tests a new drug (sEphB4-HSA) combined with standard chemotherapy in people with advanced or metastatic solid tumors, including head and neck, pancreatic, lung, and gallbladder cancers. The goal is to find the best dose and check for side effects. About 61 …
Matched conditions: STAGE IIIA NON-SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: University of Southern California • Aim: Disease control
Last updated Jun 03, 2026 12:03 UTC